Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble Hygiene and Health Care (BOM:500459) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Procter & Gamble Hygiene and Health Care Forward PE Ratio Related Terms
Procter & Gamble Hygiene and Health Care Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care Forward PE Ratio Chart
Procter & Gamble Hygiene and Health Care Annual Data
Trend
2026-03
Forward PE Ratio
32.97
Procter & Gamble Hygiene and Health Care Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
58.57
47.64
47.36
50.02
48.01
32.97
34.13
BOM:500459 vs PG, CL, EL: Forward PE Ratio Comparison
For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Hygiene and Health Care Forward PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Hygiene and Health Care's Forward PE Ratio falls into.
Procter & Gamble Hygiene and Health Care Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Forward PE Ratio of 33.64 as of Sep. 12, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. According to the industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #678 out of 759 companies in the Consumer Packaged Goods industry, placing it in the top 89.3%.
Is Procter & Gamble Hygiene and Health Care's Forward PE Ratio too high?
Procter & Gamble Hygiene and Health Care's current Forward PE Ratio is 33.64. The Consumer Packaged Goods industry median Forward PE Ratio is 12.68. Procter & Gamble Hygiene and Health Care's value of 33.64 is 165.3% above this industry median. Based on the distribution chart, Procter & Gamble Hygiene and Health Care ranks #678 out of 759 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Forward PE Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #678 out of 759 companies for Forward PE Ratio. This places Procter & Gamble Hygiene and Health Care in the lower half of its industry. The industry median Forward PE Ratio is 12.68. Procter & Gamble Hygiene and Health Care's value of 33.64 is 165.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 12.68, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Hygiene and Health Care's current Forward PE Ratio of 33.64 is 165.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 12.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Hygiene and Health Care's current Forward PE Ratio is 33.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹14,313.33, compared to a current price of ₹7,519.40 — trading 47.5% below its estimated fair value. The current Forward PE Ratio is 33.64 and 165.3% above the Consumer Packaged Goods industry median of 12.68. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Forward PE Ratio is 33.64 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued.
The current stock price of ₹7,519.40 is trading 47.5% below its estimated GF Value™ of ₹14,313.33.
GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.
Key valuation signals for BOM:500459:
Forward PE Ratio: 33.64
GF Value™: ₹14,313.33 vs. price of ₹7,519.40 (47.5% below fair value)
Industry Position: 165.3% above the Consumer Packaged Goods median (#678 of 759)
No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
76GF Score
Get the complete analysis for BOM:500459
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500459 has been successfully added to your 
